A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1)

EMBO Journal

Volumn 17, Issue 20, 1998, Pages 5987-5997

  Alevizopoulos, Konstantinos ^a   Catarin, Barbara ^a   Vlach, Jaromir ^a   Amati, Bruno ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

CDK2; E1A; E2F; p27(Kip1); Retinoblastoma

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; ONCOPROTEIN; PROTEIN P16; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GROWTH DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT;

3T3 CELLS; ADENOVIRUS E1A PROTEINS; ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; FIBROBLASTS; GROWTH INHIBITORS; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; ONCOGENE PROTEINS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEINS; VIRAL PROTEINS;

EID: 0032531871     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.20.5987     Document Type: Article

References (85)

1. Alevizopoulos, K., Vlach, J., Hennecke, S. and Amati. B. (1997) Cyclin E and c-Myc promote cell proliferation in the presence of p16INk4a and of hypophosphorylated Retinoblastoma-family proteins. EMBO J., 16, 5322-5333.
2. Amati, B., Alevizopoulos, K. and Vlach, J. (1998) Myc and the cell cycle. Frontiers Biosci., 3, d250-d268.
3. Barbeau, D., Charbonneau, R., Whalen, S.G., Bayley, S.T. and Branton, P.E. (1994) Functional interactions within adenovirus E1A protein complexes. Oncogene, 9, 359-373.
4. Bayley, S.T. and Mymryk, J.S. (1994) Adenovirus E1A proteins and transformation (Review), Int. J. Oncol., 5, 425-444.
5. 1 cyclin complexes. Genes Dev., 9, 1340-1353.
6. Blain, S.W., Montalvo, E. and Massagué, J. (1997) Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem., 272, 25863-25872.
7. 1 cyclin-dependent kinase activity. Genes Dev., 9, 2873-2887.
8. Dorsman, J.C., Hagmeyer, B.M., Veenstra, J., Elfferich, P., Nabben, N., Zantema, A. and van der Eb, A.J. (1995) The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains. J. Virol, 69, 2962-2967.
9. Du, W., Vidal, M., Xie, J.E. and Dyson, N. (1996) RBF. a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev., 10, 1206-1218.
10. 1 to S transition in Drosophila: cyclin E is a limiting downstream target of E2F. Genes Dev., 9, 1456-1468.
11. Duronio, R.J., O'Farrell, P.H., Xie, J.E., Brook, A. and Dyson, N. (1995) The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev., 9, 1445-1455.
12. Duronio, R.J., Brook, A., Dyson, N. and O'Farrel, P.H. (1996) E2F-induced S-phase entry requires cyclin E. Genes Dev., 10, 2505-2513.
13. L-S transition. Mol. Cell. Biol., 18, 141-151.
14. Dyson, N. and Harlow, E. (1992) Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv., 12, 161-195.
15. Eckner, R. (1996) p300 and CBP as transcriptional regulators and targets of oncogenic events, Biol. Chew., 377, 685-688.
16. Geng, Y., Eaton, E.N., Picon, M., Roberts, J.M., Lundberg, A.S., Gifford, A., Sardet, C. and Weinberg, R.A. (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene, 12 1173-1180.
17. Guan, K.L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X., O'Keefe, C.L., Matera, A.G. and Xiong.Y. (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952.
18. Harper, J.W. and Elledge, S.J. (1996) Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev., 6, 56-64.
19. Helin, K. (1998) Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev., 8, 28-35.
20. 1 restriction point regulation in rb-deficient fibroblasts. Mol. Cell. Biol., 16, 2402-2407.
21. Hirai, H., Roussel, M.F, Kato, J.Y., Ashmun, R.A. and Sherr, C.J. (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15, 2672-2681.
22. L exit. Genes Dev., 10, 851-861.
23. Howe, J.A. and Bayley, S.T. (1992) Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A. Virology, 186, 15-24.
24. Howe, J.A., Mymryk, J.S., Egan, C., Branton, P.E. and Bayley, S.T. (1990) Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. P roc. Natl Acad. Sci, USA, 87, 5883-5887.
25. Hurford, R.J., Cobrinik, D., Lee, M. and Dyson, N. (1997) pRB and p107/ p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev., 11, 1447-1463.
26. Iavarone, A. and Massagué, J. (1997) Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p 15. Nature, 387, 417-422.
27. Jelsma, T.N., Howe, J.A., Evelegh, C.M., Cunniff, N.F., Skiadopoulos, M.H., Floroff, M.R., Denman, J.E. and Bayley, S.T. (1988) Use of deletion and point mutants spanning the coding region of the adenovirus 5 E1A gene to define a domain that is essential for transcriptional activation. Virology, 163, 494-502.
28. Jelsma, T.N., Howe, J.A., Mymryk, J.S., EveIegh, C.M., Cunniff, N.F. and Bayley, S.T. (1989) Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer and induction of proliferating cell nuclear antigen. Virology, 171, 120-130.
29. Katayose, Y. Kim, M., Rakkar, A., Li, Z.W., Cowan, K.H. and Seth, P. (1997) Promoting apoptosis-a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res., 57, 5441-5445.
30. Kelly, B.L., Wolfe, K.G. and Roberts, J.M. (1998) Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proc. Natl Acad. Sci. USA, 95, 2535-2540.
31. Koh, J., Enders, G.H., Dynlacht, B.D. and Harlow, E. (1995) Tumourderived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature. 375, 506-510.
32. Kraus, V.B., Inostroza, J.A., Yeung, K., Reinberg, D. and Nevins, J.R. (1994) Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A. Proc. Natl Acad. Sci. USA, 91, 6279-6282.
33. Lee, J.S., Galvin, K.M., See, R.H., Eckner, R., Livingston, D., Moran, E. and Shi, Y. (1995a) Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev., 9, 1188-1198.
34. Lee, J.S., See, R.H., Galvin, K.M., Wang, J. and Shi, Y (1995b) Functional interactions between YY1 and adenovirus ElA. Nucleic Acids Res., 23, 925-931.
35. L cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol., 7, 709-712.
36. Leone, G., DeGregori, J., Sears, R., Jakoi, L. and Nevins, J.R. (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2E Nature, 387, 422-426.
37. Leone, G., DeGregori, J., Yan, Z., Jakoi, L., Ishida, S., Williams, R.S. and Nevins, J.R. (1998) E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev., 12, 2120-2130.
38. Lewis, B.A., Tullis, G., Seto, E., Horikoshi, N., Weinmann, R. and Shenk, T. (1995) Adenovirus E1A proteins interact with the cellular YY1 transcription factor. J. Virol., 69, 1628-1636.
39. 1. J. Cell Biol., 125, 625-638.
40. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol., 15, 2600-2611.
41. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G. and Bartek, J. (1995b) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature, 375, 503-506.
42. Lukas, J., Otzen Petersen, B., Holm, K., Bartek, J. and Helin, K. (1996) Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol., 16, 1047-1057.
43. Lukas, J., Herzinger, T., Hansen. K., Moroni, M., Resnitzky, D., Helin, K., Reed, S. and Bartek, J. (1997) Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev., 11, 1479-1492.
44. Lundberg, A.S. and Weinberg, R.A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-Cdk complexes. Mol. Cell. Biol., 18, 753-761.
45. Mal, A., Poon, R.Y.C., Howe, P.H., Toyoshima, H., Hunter, T. and Harter, M.L. (1996) Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature, 380, 262-265.
46. 1 cell-cycle arrest. Curr. Biol., 6, 474-483.
47. Medema, R.H., Herrera, R.E., Lam, F. and Weinberg, R.A. (1995) Growth suppression by p16INK4 requires functional retinoblastoma protein. Proc. Natl Acad. Sci. USA, 92, 6289-6293.
48. Meijer, L. (1996) Chemical inhibitors of cyclin-dependem kinases. Trends Cell Biol., 6, 393-397.
49. Mittnacht, S. (1998) Control of pRB phosphorylation. Curr. Opin. Genet. DeV., 8, 21-27.
50. Moran, E. (1993) DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev., 3, 63-70.
51. Morgan, D.O. (1995) Principles of CDK regulation. Nature. 374, 131-134.
52. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596.
53. Muller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W. and Eilers, M. (1997) Cdk2dependent phosphorylation of p27 facilitates its myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15, 2561-2576.
54. Ohtani, K., DeGregori, J. and Nevins, J.R. (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad. Sci. USA, 92, 12146-12150.
55. 1-to-S phase transition. Mol. Cell. Biol., 15, 2612-2624.
56. 1 events and regulation of cell proliferation. Science 246, 603-608.
57. Paulus, W., Baur, L., Boyce, F., Breakefield, X.O. and Reeves, S.A. (1996) Self-contained, tetracyline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol., 70, 62-67.
58. Pérez-Roger, J., Solomon, D.L.C., Sewing, A. and Land, H. (1997) Myc activation of cyclin E/CDK2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene, 14, 2373-2381.
59. Polyak, K., Lee, M.H., Erdjument, B.H., Koff, A., Roberts, J.M., Tempst, P. and Massague, J, (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
60. Prall, O.W.J., Rogan, E.M., Musgrove, E.A., Watts, C.K.W. and Sutherland, R.L. (1998) c-Myc or cyclin D1 mimics estrogen effects on cyclin E-cdk2 activation and cell cycle reentry. Mol. Cell. Biol., 18, 4499-4508.
61. Qin, X.Q., Chittenden, T., Livingston, D.M. and Kaelin, W.G., Jr. (1992) Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev., 6, 953-964.
62. Quelle, D.E, et al (1995) Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene, 11, 635-645.
63. 1to-S transition. Mol. Cell. Biol., 15, 3463-3469.
64. Reynisdottir, I. and Massagué, J. (1997) The subcellular locations of p15 (Ink4b) and p27 (Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev., 11, 492-503.
65. Reynisdottir, I., Polyak, K., lavarone, A. and Massagué, J. (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev., 9, 1831-1845.
66. Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B. Müller, R., Ansorge, W. and Eilers, M. (1996) Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J., 15, 3065-3076.
67. Sang, N.L. and Giordano, A. (1997) Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins. J, Cell Physiol, 170, 182-191.
68. 1 phase progression: cycling on cue. Cell, 79, 551-555.
69. Sherr, C.J. (1995) D-type cyclins. Trends Biochem, Sci, 20, 187-190.
70. 1 cyclindependent kinases. Genes Dev, 9, 1149-1163.
71. Somasundaram, K., Jayaraman, G., Williams, T., Moran, E., Frisch, S. and Thimmapaya, B. (1996) Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc Natl Acad. Sci USA, 93, 3088-3093.
72. Spitkovsky, D., Jansen-Durr, P., Karsenti, E. and Hoffmann, I. (1996) S- phase induction by ade no virus ElA requires activation of cdc25a tyrosine phosphatase, Oncogene, 12, 2549-2554.
73. 1 arrest induced by ultraviolet irradiation. Nature, 376, 358-362.
74. 1 cyclin- Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
75. Trouche, D. and Kouzarides, T. (1996) E2F1 and E1A (12S) have an homologous activation domain regulated by RB and CBP. Proc. Natl Acad. Sci USA. 93, 1439-1442.
76. van den Heuvel. S and Harlow, E. (1993) Distinct roles for cyclindependent kinases in cell cycle control, Science, 262, 2050-2054.
77. Klpl is abrogated by c-Myc. EMBO J., 15, 6595-6604.
78. Wang, H.G., Yaciuk, P., Ricciardi, R.P, Green, M., Yokoyama, K. and Moran, E. (1993) The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J. Virol., 67, 4804-4813.
79. Wang, X., Gorospe, M., Huang, Y. and Holbrook, N.J. (1997) p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogens, 15, 2991-2997.
80. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
81. White, R.J., Khoo, B.C., Inostroza, J.A., Reinberg. D. and Jackson, S.P. (1994) Differential regulation of RNA polymerases I, II and III by the TBP-binding repressor Dr1. Science, 266, 448-450.
82. Xiao, Z.X., Ginsberg. D., Ewen. M. and Livingston, D.M. (1996) Regulation of the retinoblastoma protein-related protein p 107 by G| cyclin-associated kinases. Proc. Natl Acad. Sci. USA, 93, 4633-4637.
83. Yan, Z., DeGregori, J., Shohet, R., Leone, G., Stillman, B., Nevins, J.R. and Williams, R.S. (1998) Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc. Natl Acad. Sci USA, 95, 3603-3608.
84. Zetterberg, A., Larsson, O. and Wiman, K.G. (1995) What is the restriction point? Curr. Opin. Cell Biol., 7, 835-842.
85. Zhao, J.Y., Dynlacht, B., Imai, T., Hori, T. and Harlow, E. (1998) Expression of NPAT, a novel substrate of cyclin E-Cdk2, promotes S-phase entry. Genes Dev., 12, 456-461.